EP4400094A1 — Pharmaceutical composition comprising large physiologically active substance and excipient
Assigned to D&D Pharmatech Inc · Expires 2024-07-17 · 2y expired
What this patent protects
The present invention relates to a pharmaceutical composition that efficiently increases the absorption rate of a large physiologically active substance in the body; and specifically to a pharmaceutical composition comprising: (i) a large physiologically active substance; and (ii…
USPTO Abstract
The present invention relates to a pharmaceutical composition that efficiently increases the absorption rate of a large physiologically active substance in the body; and specifically to a pharmaceutical composition comprising: (i) a large physiologically active substance; and (ii) excipient A comprising a bile acid derivative or (iii) excipient B comprising a compound having CYP450 inhibition, an antioxidant effect, or gastrointestinal enzyme activity inhibitory effect, and a method for preparing same.
Drugs covered by this patent
- Aubagio (TERIFLUNOMIDE) · Sanofi
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.